Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Can J Cardiol ; 37(8): 1129-1150, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-33781847

RESUMEN

The 2021 guidelines primary panel selected clinically relevant questions and produced updated recommendations, on the basis of important new findings that have emerged since the 2016 guidelines. In patients with clinical atherosclerosis, abdominal aortic aneurysm, most patients with diabetes or chronic kidney disease, and those with low-density lipoprotein cholesterol ≥ 5 mmol/L, statin therapy continues to be recommended. We have introduced the concept of lipid/lipoprotein treatment thresholds for intensifying lipid-lowering therapy with nonstatin agents, and have identified the secondary prevention patients who have been shown to derive the largest benefit from intensification of therapy with these agents. For all other patients, we emphasize risk assessment linked to lipid/lipoprotein evaluation to optimize clinical decision-making. Lipoprotein(a) measurement is now recommended once in a patient's lifetime, as part of initial lipid screening to assess cardiovascular risk. For any patient with triglycerides ˃ 1.5 mmol/L, either non-high-density lipoprotein cholesterol or apolipoprotein B are the preferred lipid parameter for screening, rather than low-density lipoprotein cholesterol. We provide updated recommendations regarding the role of coronary artery calcium scoring as a clinical decision tool to aid the decision to initiate statin therapy. There are new recommendations on the preventative care of women with hypertensive disorders of pregnancy. Health behaviour modification, including regular exercise and a heart-healthy diet, remain the cornerstone of cardiovascular disease prevention. These guidelines are intended to provide a platform for meaningful conversation and shared-decision making between patient and care provider, so that individual decisions can be made for risk screening, assessment, and treatment.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Dislipidemias/terapia , Adulto , Apolipoproteínas B/sangre , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Suplementos Dietéticos , Ácido Eicosapentaenoico/análogos & derivados , Ácido Eicosapentaenoico/uso terapéutico , Ezetimiba/uso terapéutico , Femenino , Conductas Relacionadas con la Salud , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Inhibidores de PCSK9/uso terapéutico , Embarazo , Complicaciones del Embarazo , Prevención Primaria/normas , Medición de Riesgo , Prevención Secundaria/normas
2.
J Evid Based Med ; 13(2): 137-152, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32445289

RESUMEN

OBJECTIVE: Stroke is the leading cause of death and disability in China. Chinese medicine integrated with conventional medicine is now widely used in the prevention and treatment of stroke. A clinical practice guideline for the application of integrative medicine in stroke is urgently needed. METHODS: This guideline was developed following the methodology and procedures recommended in the World Health Organization Handbook for Guideline Development and the Guideline Development Handbook for Diagnosis and Therapy of Integrative Medicine. The quality of evidence and strength of recommendations were evaluated using the GRADE approach. The guideline followed the RIGHT statement and AGREE II was consulted to ensure its quality. RESULTS: A multidisciplinary working team was established. Eleven research questions from 15 clinical questions were identified by questionnaire surveys, face-to-face meetings, and analyzed by the working team. Fourteen recommendations regarding integrative medicine for ischemic stroke, hemorrhagic stroke, and complications of stroke were formulated from systematic reviews of the benefits, harms, cost-effectiveness, quality of evidence, the values and preferences of patients and their family members, feedback on proposed recommendations from medical practitioners from a variety of disciplines, and a face-to-face consensus meeting. CONCLUSIONS: This guideline focuses on clinical treatments that are specific to integrative medicine for stroke and can be used at all levels in medical institutions and rehabilitation facilities. The end-users of the guideline are most likely to be medical practitioners, including Chinese herbal medicine specialists, acupuncturists, integrative medicine practitioners, physicians, physical therapists, and clinical pharmacists.


Asunto(s)
Medicina Integrativa/normas , Accidente Cerebrovascular/terapia , Trastornos de Deglución/etiología , Trastornos de Deglución/terapia , Depresión/etiología , Depresión/terapia , Medicamentos Herbarios Chinos/uso terapéutico , Accidente Cerebrovascular Hemorrágico/terapia , Humanos , Medicina Integrativa/métodos , Accidente Cerebrovascular Isquémico/prevención & control , Accidente Cerebrovascular Isquémico/terapia , Prevención Secundaria/métodos , Prevención Secundaria/normas , Accidente Cerebrovascular/complicaciones , Rehabilitación de Accidente Cerebrovascular/métodos , Rehabilitación de Accidente Cerebrovascular/normas , Terapia Trombolítica/métodos , Terapia Trombolítica/normas
3.
Pediatr Infect Dis J ; 38(12S Suppl): S22-S36, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31876602

RESUMEN

BACKGROUND: In recent years, new information has been acquired regarding the diagnosis, treatment and prevention of acute otitis media (AOM). The Italian Pediatric Society, therefore, decided to issue an update to the Italian Pediatric Society guidelines published in 2010. METHODS: The search was conducted on Pubmed, and only those studies regarding the pediatric age alone, in English or Italian, published between January 1, 2010 and December 31, 2018, were included. Each study included in the review was assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) methodology. The quality of the systematic reviews was evaluated using the A MeaSurement Tool to Assess systematic Reviews (AMSTAR) 2 appraisal tool. The guidelines were formulated using the GRADE methodology by a multidisciplinary panel of experts. RESULTS: The importance of eliminating risk factors (passive smoking, environmental pollution, use of pacifier, obesity, limitation of day-care center attendance) and the promotion of breastfeeding and hygiene practices (nasal lavages) was confirmed. The importance of pneumococcal vaccination in the prevention of AOM was reiterated with regard to the prevention of both the first episode of AOM and recurrences. Grommets can be inserted in selected cases of recurrent AOM that did not respond to all other prevention strategies. Antibiotic prophylaxis is not recommended for the prevention of recurrent AOM, except in certain carefully selected cases. The use of complementary therapies, probiotics, xylitol and vitamin D is not recommended. CONCLUSIONS: The prevention of episodes of AOM requires the elimination of risk factors and pneumococcal and influenza vaccination. The use of other products such as probiotics and vitamin D is not supported by adequate evidence.


Asunto(s)
Otitis Media/prevención & control , Pediatría/organización & administración , Pediatría/normas , Enfermedad Aguda , Adolescente , Niño , Preescolar , Humanos , Lactante , Italia , Factores de Riesgo , Prevención Secundaria/normas , Vacunación
5.
J Surg Res ; 244: 122-129, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31284141

RESUMEN

BACKGROUND: The objective of this study was to evaluate clinical outcomes, costs, and clinician and parent satisfaction after implementation of a protocol to discharge patients from the emergency department (ED) after successful reduction of uncomplicated ileocolic intussusception. MATERIALS AND METHODS: In March 2017, an intussusception management protocol was implemented for children presenting with ultrasound findings of ileocolic intussusception. Those meeting inclusion criteria were observed after successful radiological reduction in the ED and discharged after 6 h with resolution of symptoms. Retrospective chart review was completed for cases before and after protocol implementation for clinical outcomes and costs. Clinicians and parents were surveyed to assess overall satisfaction. RESULTS: Charts were reviewed before (42 encounters, 37 patients) and after (30 encounters, 23 patients) protocol implementation. After implementation, admission rates decreased from 95% (40/42) to 23% (7/30; P < 0.001) and antibiotic use was eliminated (91% to 0%, P < 0.001). There was no difference in recurrence rates (17% versus 23%, P = 0.44). Median total length of stay decreased from 18.87 to 9.52 h (P < 0.001), whereas median ED length of stay increased from 4.37 to 9.87 h (P < 0.001). In addition, there was an overall hospital cost saving of over $2000 ($9595 ± 3424 to $7465 ± 3723; P = 0.009) per encounter. Clinicians and parents were overall satisfied with the protocol and parents showed no changes in patient satisfaction with protocol implementation. CONCLUSIONS: An intussusception protocol can facilitate early discharge from the ED and improve patient care without increased risk of recurrence. Additional benefits include decreased hospital- and patient-related costs, elimination of antibiotic use, and parent as well as clinician satisfaction.


Asunto(s)
Protocolos Clínicos/normas , Implementación de Plan de Salud , Enfermedades del Íleon/terapia , Intususcepción/terapia , Satisfacción Personal , Preescolar , Servicio de Urgencia en Hospital/economía , Servicio de Urgencia en Hospital/organización & administración , Servicio de Urgencia en Hospital/normas , Enema , Femenino , Costos de Hospital/estadística & datos numéricos , Humanos , Enfermedades del Íleon/economía , Lactante , Recién Nacido , Intususcepción/economía , Tiempo de Internación/economía , Tiempo de Internación/estadística & datos numéricos , Masculino , Alta del Paciente/normas , Evaluación de Programas y Proyectos de Salud , Mejoramiento de la Calidad , Estudios Retrospectivos , Prevención Secundaria/economía , Prevención Secundaria/organización & administración , Prevención Secundaria/normas , Encuestas y Cuestionarios/estadística & datos numéricos
6.
Osteoporos Int ; 30(9): 1779-1788, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31190123

RESUMEN

The purpose of this study was to assess the performance of our Fracture Liaison Service (FLS) over a period of 2 years. Osteoporosis medication was prescribed for 243 patients, and zoledronic acid was the main drug prescribed (60.2%). INTRODUCTION: A Fracture Liaison Service (FLS) was implemented at Lille University Hospital in 2016. The main purpose of this study was to assess the performance of the FLS using criteria proposed by the International Osteoporosis Foundation (IOF). METHODS: The criteria used were patient identification, patient evaluation, post-fracture assessment timing, vertebral-fracture identification, blood and bone mineral density (BMD) testing, falls prevention, multifaceted health and lifestyle risk-factor assessment, and medication initiation and review. RESULTS: Between January 2016 and January 2018, 736 patients (≥ 50 years old) with a recent history of fragility fracture (≤ 12 months) were identified. The identification rate for hip fractures was 74.2%. However, patient evaluation for all type of fractures was quite low (30.3%) since many patients failed to attend the FLS unit. The reasons for non-attendance were refusal, agreed but subsequently failed to attend, and still waiting to be seen. In all, 256 patients (76.6% female, mean (SD) age 74.3 (11.0) years) were seen at the FLS. Mean (SD) post-fracture assessment timing was 13.3 (9.3) weeks. Of the 139 patients seen for a non-vertebral fracture, 103 were assessed for vertebral fractures, and at least one new vertebral fracture was found in 45 of them (43.7%). Osteoporosis medication was prescribed for 243 (94.9%) patients. The main osteoporosis drug prescribed was zoledronic acid (60.2%). CONCLUSIONS: Secondary prevention of osteoporotic fractures has improved since the implementation of the FLS. However, patient identification, patient evaluation, and post-fracture assessment timing still need to be improved.


Asunto(s)
Fracturas Osteoporóticas/prevención & control , Prevención Secundaria/métodos , Accidentes por Caídas/prevención & control , Anciano , Anciano de 80 o más Años , Conservadores de la Densidad Ósea/uso terapéutico , Comunicación , Vías Clínicas/organización & administración , Prestación Integrada de Atención de Salud/organización & administración , Prestación Integrada de Atención de Salud/normas , Femenino , Francia/epidemiología , Investigación sobre Servicios de Salud/métodos , Hospitales Universitarios/organización & administración , Hospitales Universitarios/normas , Humanos , Estilo de Vida , Masculino , Persona de Mediana Edad , Pacientes no Presentados/estadística & datos numéricos , Osteoporosis/tratamiento farmacológico , Osteoporosis/epidemiología , Fracturas Osteoporóticas/epidemiología , Indicadores de Calidad de la Atención de Salud , Estudios Retrospectivos , Medición de Riesgo/métodos , Prevención Secundaria/organización & administración , Prevención Secundaria/normas
9.
J Am Heart Assoc ; 6(10)2017 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-28963100

RESUMEN

Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions that can contribute to the primary and secondary prevention of cardiovascular disease are of interest. Numerous studies have reported on the benefits of meditation. Meditation instruction and practice is widely accessible and inexpensive and may thus be a potential attractive cost-effective adjunct to more traditional medical therapies. Accordingly, this American Heart Association scientific statement systematically reviewed the data on the potential benefits of meditation on cardiovascular risk. Neurophysiological and neuroanatomical studies demonstrate that meditation can have long-standing effects on the brain, which provide some biological plausibility for beneficial consequences on the physiological basal state and on cardiovascular risk. Studies of the effects of meditation on cardiovascular risk have included those investigating physiological response to stress, smoking cessation, blood pressure reduction, insulin resistance and metabolic syndrome, endothelial function, inducible myocardial ischemia, and primary and secondary prevention of cardiovascular disease. Overall, studies of meditation suggest a possible benefit on cardiovascular risk, although the overall quality and, in some cases, quantity of study data are modest. Given the low costs and low risks of this intervention, meditation may be considered as an adjunct to guideline-directed cardiovascular risk reduction by those interested in this lifestyle modification, with the understanding that the benefits of such intervention remain to be better established. Further research on meditation and cardiovascular risk is warranted. Such studies, to the degree possible, should utilize randomized study design, be adequately powered to meet the primary study outcome, strive to achieve low drop-out rates, include long-term follow-up, and be performed by those without inherent bias in outcome.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Meditación , Prevención Primaria/métodos , Prevención Secundaria/métodos , American Heart Association , Presión Sanguínea , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/fisiopatología , Enfermedades Cardiovasculares/psicología , Endotelio Vascular/fisiopatología , Humanos , Resistencia a la Insulina , Prevención Primaria/normas , Factores de Riesgo , Conducta de Reducción del Riesgo , Prevención Secundaria/normas , Fumar/efectos adversos , Fumar/epidemiología , Fumar/psicología , Cese del Hábito de Fumar , Resultado del Tratamiento , Estados Unidos
10.
Osteoporos Int ; 28(10): 2913-2919, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-28664275

RESUMEN

This study of current osteoporosis management patterns in general practice found that the majority of patients presenting to their local health practitioner with a recent low-trauma fracture was not managed appropriately. The analysis demonstrated that failure to investigate was highly predictive of failure to treat and that one of the major barriers to effective osteoporosis management is a lack of specific knowledge about who to investigate and treat. INTRODUCTION: Osteoporotic fractures are associated with significant morbidity and mortality. The current study aimed (i) to determine the number of patients with osteoporotic fractures who were not investigated or treated for osteoporosis by their primary care physician and (ii) to identify factors that contribute to the ongoing gap in osteoporosis care. METHODS: We conducted an observational retrospective study (2012-2014) using explicit medical record review at three major general practices in metropolitan Sydney. Patients aged 55 years or older who had a documented minimal trauma fracture (MTF) were identified. Data collected included demographics, prior fractures, testing for vitamin D/bone mineral density and initiation of osteoporosis pharmacotherapy. The main outcome measures included the number of patients who did not undergo the following: (i) a bone density scan, (ii) vitamin D measurement and/or (iii) initiation of osteoporosis pharmacotherapy. RESULTS: Of the 87 patients (69% female; mean age 71.7 years) with prevalent MTF, 55 (63%) were not referred for a bone density scan. Vitamin D levels were not measured in 36 patients (41%) and 55 patients (63%) did not receive specific osteoporosis pharmacotherapy. Failure to investigate was highly predictive of failure to treat (p < 0.001). The presence of major osteoporotic risk factors did not affect the likelihood of investigation or treatment, indicating that a major barrier to effective osteoporosis management was a lack of knowledge. CONCLUSION: Management of patients with MTF's in primary care is poor. Systems aimed at improving the identification and treatment of patients with osteoporotic fractures in this setting is required in order to close the osteoporosis care gap.


Asunto(s)
Fracturas Osteoporóticas/prevención & control , Atención Primaria de Salud/métodos , Prevención Secundaria/métodos , Anciano , Anciano de 80 o más Años , Densidad Ósea , Conservadores de la Densidad Ósea/uso terapéutico , Suplementos Dietéticos , Manejo de la Enfermedad , Utilización de Medicamentos/estadística & datos numéricos , Medicina Familiar y Comunitaria/métodos , Medicina Familiar y Comunitaria/normas , Femenino , Humanos , Masculino , Persona de Mediana Edad , Nueva Gales del Sur , Osteoporosis/diagnóstico , Osteoporosis/tratamiento farmacológico , Osteoporosis/fisiopatología , Fracturas Osteoporóticas/fisiopatología , Recurrencia , Estudios Retrospectivos , Prevención Secundaria/normas , Prevención Secundaria/estadística & datos numéricos , Vitamina D/sangre , Vitamina D/uso terapéutico
11.
Arch Osteoporos ; 12(1): 60, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28656564

RESUMEN

This study aims at assessing the gap in secondary fracture prevention at a regional general hospital setting in Singapore. Male patients have significantly lower rate of being investigated and treated for osteoporosis than their female counterparts. Vitamin D deficiency is prevalent in our population. PURPOSE: Secondary fracture prevention services are not routine in Singapore; we seek to assess the treatment gap that exists in the lack of diagnosis and treatment of osteoporosis in fragility fracture patients. METHODS: We performed a retrospective analysis of all admissions for fragility fractures between December 2013 and December 2014. Demographic data, rates of BMD performance, serum vitamin D investigation and calcium and vitamin D supplementation as well as antiresorptive initiation 1 year post admission were analysed. RESULTS: There were 125 fragility fractures in patients below 65 and 615 fractures in older patients. There was a slightly higher proportion of males in the younger population, whereas females predominated in the older population. Median vitamin D levels were low in both younger (19.1 µg/L) and older (22.0 µg/L) groups, but supplementation was lower in younger patients (4.8 versus 16.6%, p = 0.003). Rate of BMD performance was lower in younger patients (34.4 versus 64.6%, p < 0.01); there was a significant difference of BMD performance between male and female patients in the younger population (19.1 versus 52.8%, p < 0.01) which was not present in the older age group. Antiresportive initiation was significantly lower in the younger age group versus older (10.4 versus 31.5%, p < 0.01); male patients in the younger and older age groups had significantly lower antiresorptive initiation rate compared to the females. CONCLUSION: There is a significant treatment gap in diagnosis and treatment of osteoporosis in fragility fracture patients in a regional hospital setting in Singapore. Male osteoporosis remains inadequately investigated and treated in both age groups.


Asunto(s)
Osteoporosis/diagnóstico , Fracturas Osteoporóticas/prevención & control , Adulto , Factores de Edad , Anciano , Conservadores de la Densidad Ósea/uso terapéutico , Suplementos Dietéticos/estadística & datos numéricos , Utilización de Medicamentos/estadística & datos numéricos , Femenino , Hospitalización , Hospitales Generales/normas , Humanos , Masculino , Persona de Mediana Edad , Osteoporosis/tratamiento farmacológico , Osteoporosis/epidemiología , Fracturas Osteoporóticas/epidemiología , Prevalencia , Calidad de la Atención de Salud , Recurrencia , Estudios Retrospectivos , Prevención Secundaria/métodos , Prevención Secundaria/normas , Factores Sexuales , Singapur/epidemiología , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/complicaciones , Deficiencia de Vitamina D/epidemiología , Adulto Joven
12.
Ophthalmologe ; 114(1): 24-29, 2017 Jan.
Artículo en Alemán | MEDLINE | ID: mdl-27566176

RESUMEN

BACKGROUND: Epidemiologic data demonstrate a rise in myopia prevalence. Therefore interventions to reduce the risk of myopia and its progression are needed and increasingly often asked for. METHODS: Systematic literature search via PubMed in MEDLINE. RESULTS: Myopia progression can be reduced by the following means which are listed according to their efficacy: (1) Atropine eye drops low dosed to avoid clinically relevant side effects, (2) optical means aiming at the correction of peripheral hyperopic defocus, e. g., multifocal contact lenses, and (3) increased daylight exposure. CONCLUSION: Daylight exposure reduces the risk of incident myopia. Children should be advised to spend sufficient time outdoors, especially before and in primary school. Myopia progression can be effectively attenuated by low-dose topical atropine and multifocal contact lenses.


Asunto(s)
Atropina/administración & dosificación , Lentes de Contacto , Miopía/prevención & control , Oftalmología/normas , Fototerapia/métodos , Guías de Práctica Clínica como Asunto , Terapia Combinada/métodos , Progresión de la Enfermedad , Medicina Basada en la Evidencia , Alemania , Humanos , Miopía/diagnóstico , Soluciones Oftálmicas/administración & dosificación , Prevención Secundaria/normas , Resultado del Tratamiento
13.
Nervenarzt ; 87(8): 860-9, 2016 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-27072795

RESUMEN

BACKGROUND: Post-stroke care programs based on a standardized treatment pathway supported by case management may prevent secondary stroke and minimize risk factors. OBJECTIVES: We aimed to determine the feasibility of a standardized treatment pathway and its impact on risk factor control, life-style changes and adherence to secondary prevention medication. METHODS: We conducted a prospective pilot study in consecutive stroke patients. The 12-month post-stroke care program included regular perosnal and phone contact with a certified case manager. Target values for vascular risk factors following current recommendations of stroke guidelines were monitored and treated if necessary. In the case of deviations from the treatment pathway the case manager intervened. Patients were screened for recurrent stroke at the end of the program after 12 months. RESULTS: We enrolled 101 patients: 57.4 % were male, the median age was 72 (IQR, 62-80) years, median baseline NIHSS score was 2(IQR, 1-5), 79.2 % had an ischemic stroke, 3 % a hemorrhagic stroke, and 17.8 % a transient ischemic attack (TIA). Eighty-six (85.1 %) patients completed the program, 12 (11.9 %) withdrew from the program and 3 died of malignant diseases. In total, 628 personal (6.2/patient) and 2,683 phone contacts (26.6/patient) were conducted by the case manager. Three hundred-seventy-nine specific interventions were necessary mostly because of missing medication, non-compliance, and social needs. After 12 months, target goals for blood pressure, body mass index, nicotine use, and cholesterol were more frequently (p < 0.05) achieved than at baseline. No recurrent stroke occurred during the program. CONCLUSIONS: Our pilot data demonstrate that case management-based post-stroke care is feasible and may contribute to effective secondary prevention of stroke.


Asunto(s)
Cuidados Posteriores/estadística & datos numéricos , Vías Clínicas/estadística & datos numéricos , Vías Clínicas/normas , Prevención Secundaria/estadística & datos numéricos , Rehabilitación de Accidente Cerebrovascular/estadística & datos numéricos , Accidente Cerebrovascular/terapia , Cuidados Posteriores/métodos , Cuidados Posteriores/normas , Anciano , Anciano de 80 o más Años , Manejo de Caso/normas , Manejo de Caso/estadística & datos numéricos , Femenino , Alemania/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Guías de Práctica Clínica como Asunto , Prevalencia , Prevención Secundaria/métodos , Prevención Secundaria/normas , Accidente Cerebrovascular/diagnóstico , Rehabilitación de Accidente Cerebrovascular/métodos , Rehabilitación de Accidente Cerebrovascular/normas
14.
Osteoporos Int ; 27(2): 683-90, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26286624

RESUMEN

UNLABELLED: The aims of this study are to develop a cloud-based application of the Fracture Liaison Service for practitioners to coordinate the care of osteoporotic patients after suffering primary fractures and provide a performance feedback portal for practitioners to determine quality of care. The application provides continuity of care, improved patient outcomes, and reduced medical costs. INTRODUCTION: The purpose of this study is to describe the content development and functionality of a cloud-based application to broadly deploy the Fracture Liaison Service (FLS) to coordinate post-fracture care for osteoporotic patients. METHODS: The Bone Health Collaborative developed the FLS application in 2013 to support practitioners' access to information and management of patients and provide a feedback portal for practitioners to track their performance in providing quality care. A five-step protocol (identify, inform, initiate, investigate, and iterate) organized osteoporotic post-fracture care-related tasks and timelines for the application. A range of descriptive data about the patient, their medical condition, therapies and care, and current providers can be collected. Seven quality of care measures from the National Quality Forum, The Joint Commission, and the Centers for Medicare and Medicaid Services can be tracked through the application. RESULTS: There are five functional areas including home, tasks, measures, improvement, and data. The home, tasks, and data pages are used to enter patient information and coordinate care using the five-step protocol. Measures and improvement pages are used to enter quality measures and provide practitioners with continuous performance feedback. The application resides within a portal, running on a multitenant, private cloud-based Avedis enterprise registry platform. All data are encrypted in transit and users access the application using a password from any common web browser. CONCLUSION: The application could spread the FLS model of care across the US health care system, provide continuity of care, effectively manage osteoporotic patients, improve outcomes, and reduce medical costs.


Asunto(s)
Nube Computacional , Prestación Integrada de Atención de Salud/organización & administración , Modelos Organizacionales , Fracturas Osteoporóticas/prevención & control , Conservadores de la Densidad Ósea/uso terapéutico , Protocolos Clínicos , Prestación Integrada de Atención de Salud/normas , Humanos , Colaboración Intersectorial , Osteoporosis/tratamiento farmacológico , Prevención Secundaria/organización & administración , Prevención Secundaria/normas , Estados Unidos
15.
Prev Chronic Dis ; 12: E163, 2015 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-26425867

RESUMEN

INTRODUCTION: Since the introduction of the Affordable Care Act (ACA) in 2012, 11 million more Americans now have access to preventive services via health care coverage. Several prevention-related recommendations issued by the US Preventive Services Task Force (USPSTF), Centers for Disease Control and Prevention (CDC), and Advisory Committee on Immunization Practices (ACIP) are covered under the ACA. State cancer plans often provide prevention strategies, but whether these strategies correspond to federal evidence-based recommendations is unclear. The objective of this article is to assess whether federal evidence-based recommendations, including those covered under the ACA, are included in the Maryland Comprehensive Cancer Control Plan (MCCCP). METHODS: A total of 19 federal recommendations pertaining to cancer prevention and control were identified. Inclusion of federal cancer-related recommendations by USPSTF, CDC, and ACIP in the MCCCP's goals, objectives, and strategies was examined. RESULTS: Nine of the federal recommendations were issued after the MCCCP's publication. MCCCP recommendations corresponded completely with 4 federal recommendations and corresponded only partially with 3. Reasons for partial correspondence included specification of less restrictive at-risk populations or different intervention implementers. Three federal recommendations were not mentioned in the MCCCP's goals, objectives, and strategies. CONCLUSION: Many cancer-related federal recommendations were released after the MCCCP's publication and therefore do not appear in the most current version. We recommend that the results of this analysis be considered in the update of the MCCCP. Our findings underscore the need for a periodic scan for changes to federal recommendations and for adjusting state policies and programs to correspond with federal recommendations, as appropriate for Marylanders.


Asunto(s)
Atención Integral de Salud/métodos , Agencias Gubernamentales , Adhesión a Directriz/estadística & datos numéricos , Neoplasias/prevención & control , Patient Protection and Affordable Care Act/normas , Comités Consultivos , Centers for Disease Control and Prevention, U.S. , Práctica Clínica Basada en la Evidencia/métodos , Adhesión a Directriz/normas , Humanos , Programas de Inmunización/normas , Maryland , Objetivos Organizacionales , Prevención Secundaria/normas , Estados Unidos
16.
Actas dermo-sifiliogr. (Ed. impr.) ; 106(7): 533-544, sept. 2015. tab, ilus
Artículo en Español | IBECS | ID: ibc-143899

RESUMEN

El manejo del eczema de manos es complejo, ya que engloba eczemas de etiopatogenia, curso y pronóstico muy diferentes; la mayoría de tratamientos disponibles no cuentan con niveles de eficacia establecidos, y en sus formas graves la calidad de vida se afecta de forma importante. La educación del paciente, las medidas de protección y el uso de emolientes constituyen un pilar fundamental en el abordaje de estos pacientes. Los corticoides tópicos de alta potencia son el tratamiento de elección, seguidos de los inhibidores de la calcineurina para el mantenimiento de la enfermedad. En los casos refractarios a estos tratamientos deberíamos utilizar la fototerapia o tratamientos sistémicos, los cuales no deberían demorarse para evitar sensibilizaciones, bajas laborales y alteración en la calidad de vida. La alitretinoína es el único tratamiento oral disponible que ha sido aprobado para su utilización en el eczema crónico de manos


Management of hand eczema is complex because of the broad range of different pathogeneses, courses, and prognoses. Furthermore, the efficacy of most available treatments is not well established and the more severe forms can have a major impact on the patient's quality of life. Patient education, preventive measures, and the use of emollients are the mainstays in the management of hand eczema. High-potency topical corticosteroids are the treatment of choice, with calcineurin inhibitors used for maintenance. Phototherapy or systemic treatments are indicated in patients who do not respond to topical treatments. Switching from topical treatments should not be delayed to avoid sensitizations, time off work, and a negative impact on quality of life. Alitretinoin is the only oral treatment approved for use in chronic hand eczema


Asunto(s)
Femenino , Humanos , Masculino , Eccema/metabolismo , Eccema/patología , Mano/patología , /normas , Calcineurina/provisión & distribución , Terapéutica/métodos , Calidad de Vida/psicología , Prevención Primaria/métodos , Prevención Secundaria/educación , Prevención Terciaria/métodos , Eccema/diagnóstico , Mano/crecimiento & desarrollo , Calcineurina/uso terapéutico , Terapéutica/tendencias , Terapéutica , Calidad de Vida/legislación & jurisprudencia , Prevención Primaria , Prevención Secundaria/normas , Prevención Terciaria , Educación del Paciente como Asunto/clasificación
17.
Unfallchirurg ; 118(8): 652-6, 2015 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-26160129

RESUMEN

BACKGROUND: In order to ensure adequate treatment and to avoid complications, care bundles are increasingly being implemented. These are comprehensive and evidence-based procedures for the treatment of individual diseases or injuries which should be carried out for every patient. The aim of this study was to define a care bundle for the prehospital treatment of severely injured patients. MATERIAL AND METHODS: The scientific contents of the bundle were gathered from the interdisciplinary evidence-based S3 guidelines for the treatment of severely injured patients by the German Trauma Society. The ABCDE scheme suggested by the prehospital trauma life support (PHTLS®) and the advanced trauma life support (ATLS®) functioned as a matrix for the individual elements in the bundles. The identified elements were finalized by a consensus process. RESULTS AND DISCUSSION: A bundle of six elements was suggested and a comprehensive summary of key items during prehospital management of severely injured patients was identified. In a next step the effectiveness of the care bundle should be evaluated in a clinical trial.


Asunto(s)
Cuidados Críticos/normas , Servicios Médicos de Urgencia/normas , Paquetes de Atención al Paciente/normas , Guías de Práctica Clínica como Asunto , Traumatología/normas , Heridas y Lesiones/terapia , Algoritmos , Continuidad de la Atención al Paciente/normas , Vías Clínicas/normas , Alemania , Humanos , Prevención Secundaria/normas , Índices de Gravedad del Trauma , Heridas y Lesiones/diagnóstico
18.
Osteoporos Int ; 26(11): 2573-8, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26070301

RESUMEN

UNLABELLED: Fracture Liaison Services are the best model to prevent secondary fractures. The International Osteoporosis Foundation developed a Best Practice Framework to provide a quality benchmark. After a year of implementation, we confirmed that a single framework with set criteria is able to benchmark services across healthcare systems worldwide. INTRODUCTION: Despite evidence for the clinical effectiveness of secondary fracture prevention, translation in the real-world setting remains disappointing. Where implemented, a wide variety of service models are used to deliver effective secondary fracture prevention. To support use of effective models of care across the globe, the International Osteoporosis Foundation's Capture the Fracture® programme developed a Best Practice Framework (BPF) tool of criteria and standards to provide a quality benchmark. We now report findings after the first 12 months of implementation. METHODS: A questionnaire for the BPF was created and made available to institutions on the Capture the Fracture website. Responses from institutions were used to assign gold, silver, bronze or black (insufficient) level of achievements mapped across five domains. Through an interactive process with the institution, a final score was determined and published on the Capture the Fracture website Fracture Liaison Service (FLS) map. RESULTS: Sixty hospitals across six continents submitted their questionnaires. The hospitals served populations from 20,000 to 15 million and were a mix of private and publicly funded. Each FLS managed 146 to 6200 fragility fracture patients per year with a total of 55,160 patients across all sites. Overall, 27 hospitals scored gold, 23 silver and 10 bronze. The pathway for the hip fracture patients had the highest proportion of gold grading while vertebral fracture the lowest. CONCLUSION: In the first 12 months, we have successfully tested the BPF tool in a range of health settings across the globe. Initial findings confirm a significant heterogeneity in service provision and highlight the importance of a global approach to ensure high quality secondary fracture prevention services.


Asunto(s)
Benchmarking , Fracturas Osteoporóticas/prevención & control , Prevención Secundaria/normas , Prestación Integrada de Atención de Salud/organización & administración , Prestación Integrada de Atención de Salud/normas , Encuestas de Atención de la Salud , Fracturas de Cadera/epidemiología , Fracturas de Cadera/prevención & control , Humanos , Fracturas Osteoporóticas/epidemiología , Guías de Práctica Clínica como Asunto , Prevención Secundaria/organización & administración , Fracturas de la Columna Vertebral/epidemiología , Fracturas de la Columna Vertebral/prevención & control
20.
Eur J Prev Cardiol ; 20(3): 468-79, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22508693

RESUMEN

Over the past decades undisputable evidence has accumulated identifying the panoply of beneficial effects of exercise training, smoking cessation, blood pressure lowering, glycaemic and lipid control, as well as psycho-social interventions on cardiovascular risk factors, the well-being, morbidity and mortality of patients with cardiac diseases with or without acute events. Nevertheless, despite all the evidence, insurance companies are more than hesitant to provide patients with an adequate infrastructure to allow outpatient cardiac rehabilitation in their community. Whereas some countries still favour in-hospital rehabilitation, others are on the verge of introducing cardiac rehabilitation for the first time. Thanks to the efforts of the Working Group of Outpatient Cardiac Rehabilitation of the Austrian Cardiac Society, detailed guidelines for outpatient cardiac rehabilitation have been introduced, which not only include aims, contents and duration of outpatient cardiac rehabilitation, but also requirements for staff, quality of care and infrastructure. As a result cardiac rehabilitation in Austria is currently undergoing a transition process from exclusive in-hospital cardiac rehabilitation to a more open approach of granting patients a choice between in-hospital and outpatient rehabilitation. Experience gained appears relevant to a great number of colleagues in many countries Europe - as well as worldwide. Since these guidelines were and still are the basis for implementing outpatient cardiac rehabilitation, they are presented in great detail, so that they may either be applied as is or simply stimulate discussion.


Asunto(s)
Atención Ambulatoria/organización & administración , Prestación Integrada de Atención de Salud/organización & administración , Accesibilidad a los Servicios de Salud/organización & administración , Cardiopatías/rehabilitación , Modelos Organizacionales , Conducta de Reducción del Riesgo , Prevención Secundaria/organización & administración , Atención Ambulatoria/normas , Austria , Habilitación Profesional , Prestación Integrada de Atención de Salud/normas , Educación Médica , Accesibilidad a los Servicios de Salud/normas , Cardiopatías/diagnóstico , Humanos , Grupo de Atención al Paciente/organización & administración , Guías de Práctica Clínica como Asunto , Desarrollo de Programa , Factores de Riesgo , Prevención Secundaria/educación , Prevención Secundaria/normas , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA